Status: Not yet recruiting
" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "
The primary aim of this study is to investigate the association between metabolic syndrome and erythropoietin resistance in patients with End-Stage Kidney Disease (ESKD).
Participants needed: 66
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fayoum UniversityUpdated: May 21, 2025
Eligibility criteria
Patients (and replacements) will be randomly selected by a raffle. [+2]
- Patients with neoplasm, severe cardiovascular, cerebrovascular and liver disea... [+2]